首页> 外文期刊>Frontiers in Medicine >Prognostic Value and Clinical Impact of 18FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy
【24h】

Prognostic Value and Clinical Impact of 18FDG-PET in the Management of Children with Burkitt Lymphoma after Induction Chemotherapy

机译:18FDG-PET在Burkitt淋巴瘤小儿诱导化疗后的治疗中的预后价值和临床影响

获取原文
           

摘要

Objective: Burkitt lymphoma (BL) is a rare and aggressive form of B-cell lymphoma that is curable using intensive chemotherapy. Obtaining a complete response (CR) at the end of induction chemotherapy is a major prognostic factor. This study retrospectively evaluates the potential impact of 18FDG-PET in the management of children with BL after induction chemotherapy, and the prognostic performance of the Deauville criteria.
机译:目的:Burkitt淋巴瘤(BL)是一种罕见的侵袭性B细胞淋巴瘤,可通过强化化疗治愈。在诱导化疗结束时获得完全缓解(CR)是主要的预后因素。这项研究回顾性评估了18FDG-PET在诱导化疗后的BL儿童管理中的潜在影响,以及多维尔标准的预后表现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号